Previous studies have demonstrated that PR signaling exerts a critical modulatory effect on estrogen receptor alpha (ERα) activity within the breast cancer microenvironment, influencing both tumor biology and therapeutic responsiveness [30–33]. Here, ESR1 is linked to neoplasm.